INR Targets and Management Before Surgery After Warfarin Discontinuation

INR Thresholds by Surgical Bleeding Risk

Standard (moderate‑risk) surgeries—including general, orthopedic, and abdominal procedures—should be performed only when the patient’s INR is ≤ 1.5. This threshold is endorsed by multiple Anaesthesia and Blood society guidelines published between 2012 and 2025. 1
Very high‑risk procedures (e.g., neurosurgery, neuraxial anesthesia, selected hepatic surgeries) require a stricter INR ≤ 1.2. The recommendation is supported by Anaesthesia guidelines and the Canadian Cardiology guideline. 8
Low‑risk procedures (e.g., dental work, minor dermatologic interventions) may proceed without stopping warfarin if the INR is therapeutic, but a target of ≤ 1.5 is still advised. 8

Large retrospective cohort (≈ 636 000 patients) demonstrated that an INR of 1.0–1.49 is associated with a higher 30‑day major hemorrhage rate compared with INR < 1.0. (Retrospective observational evidence.) 1
Analysis of 17 500 hip‑replacement patients showed increased peri‑operative bleeding when INR was 1.25–1.5 versus < 1.0. (Observational cohort.) 1

Standard protocol: discontinue warfarin 5 days before the scheduled operation (equivalent to withholding five doses). Recommended by Blood society guidelines. 3
In patients whose baseline INR is 2.0–3.0, a 5‑day washout typically lowers the INR to ≤ 1.5 within ≈ 115 hours (≈ 5 days). (Pharmacokinetic modelling data.) 3
INR should be re‑checked 1–2 days prior to surgery to confirm that the target has been achieved. (Routine peri‑operative monitoring.) 3

If INR is > 1.5 but ≤ 1.8 on the day before surgery, administer a low‑dose oral vitamin K (1–2.5 mg). (Guideline‑based reversal strategy.) 3
When surgery is scheduled within 12 hours and INR > 1.5, give prothrombin complex concentrate (PCC) at the SmPC‑specified dose plus 5 mg vitamin K (IV or oral), then re‑measure INR within 30 minutes. (Rapid reversal protocol.) 1
If surgery is > 12 hours away and INR > 1.5, provide 5 mg vitamin K intravenously (no PCC), and repeat INR testing before the procedure. (Standard reversal without PCC.) 1

Elderly patients experience a slower decline in INR after warfarin cessation and therefore may need a longer washout period. (Age‑related pharmacodynamic effect.) 3
Higher baseline INR values (e.g., 3.0–4.0) predict a prolonged time to reach the target INR, necessitating an extended interruption. (Baseline INR as the strongest predictor of slow normalization.) 3

Patients with high thrombotic risk (mechanical mitral valve, recent venous thromboembolism, antiphospholipid syndrome) may receive low‑molecular‑weight heparin bridging, but the same INR thresholds apply before surgery (≤ 1.5 for standard procedures, ≤ 1.2 for very high‑risk procedures). (Guideline consensus.) 9

Do not proceed with surgery if the INR exceeds the procedure‑specific thresholds (> 1.5 for standard, > 1.2 for very high‑risk surgeries) because bleeding complications rise markedly. (Evidence from Anaesthesia cohort studies.) 1
Always verify the INR on the day of surgery, especially in elderly patients or those with high baseline INR, rather than assuming a 5‑day washout is sufficient for everyone. (Clinical safety reminder.) 1